发明名称 APOPTOSIS INHIBITORS
摘要 Apoptosis inhibitors containing as the active ingredient compounds represented by general formula (I) or salts thereof, wherein W1 represents -O-, -CH2-, etc.; W2 represents -CH2-, etc.; W3 represents -O-, -CH2-, etc.; X represents CH, C-, etc.; and A represents formula (.alpha.) wherein W4 represents -O-, CH2-, etc.; W5 represents -CH2-, etc.; and W6 represents -O-, -CH2-, etc. These apoptosis inhibitors inhibit apoptosis of WC8 cells induced by Fas ligand. In animal models, they potently inhibit the progress of fulminant hepatitis and relieve alopecia caused by anticancer agents. Because of being highly safe, these apoptosis inhibitors are usable as beneficial drugs.
申请公布号 CA2314954(A1) 申请公布日期 1999.06.24
申请号 CA19982314954 申请日期 1998.12.15
申请人 MOCHIDA PHARMACEUTICAL CO., LTD. 发明人 SAITOH, FUMIHIKO;TAKIGUCHI, KAZUHIKO;SATOH, TSUTOMU;TSUDA, TOSHIHIKO;KATO, KAZUO
分类号 A61K31/075;A61K31/09;A61K31/10;A61K31/122;A61K31/357;A61K31/366;A61K31/382;A61K31/397;A61K31/4025;A61K31/4178;A61K31/4433;A61K31/453;A61K31/496;A61K31/5377;A61K31/55;C07C45/45;C07C45/51;C07C45/75;C07C49/417;C07C49/517;C07C49/723;C07C49/753;C07C323/12;C07D309/38;C07D319/06;C07D319/16;C07D335/02;C07D405/06;C07D495/10;C07D519/00;C07D521/00;(IPC1-7):C07C49/417;C07D407/06;C07D319/08;A61K31/12;C07D309/32;A61K31/335;A61K31/37;A61K31/38 主分类号 A61K31/075
代理机构 代理人
主权项
地址